Overview

Safety & Efffficacy of Genakumab in Patients With Frequent Flares

Status:
COMPLETED
Trial end date:
2024-04-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Genakumab Injection in patients with Gouty Arthritis (GA).
Phase:
PHASE3
Details
Lead Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.
Treatments:
betamethasone dipropionate, betamethasone sodium phosphate drug combination